Hodgo

$PAA - doggy spec biotech basing up.

ASX:PAA   PHARMAUST LIMITED
after the pump through 19 recently this thing has come back and tested support. Id suggest clearly not being bought up by funds. However, looking much better for a test of resistance on the hourly at 22.5c.

From the recent presentation, the next move was to test their drug against human lung tissue to test its impact on covid infected cells.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.